- Published on
Ophthalmology – Brown Syndrome
Brown syndrome is an ocular motility disorder characterized by a restriction of elevation when the eye is in adduction. This limitation may occur with both active and passive movement and is typically caused by abnormal function of the superior oblique tendon–trochlea complex. The condition can be congenital or acquired and varies in severity from mild limitation to complete restriction of elevation in adduction.
Epidemiologically, Brown syndrome is relatively uncommon, occurring in approximately 1 in 450 cases of strabismus. It can present at any age, though congenital cases are often detected in childhood, while acquired cases may occur later in life due to trauma or inflammatory conditions. Rare familial cases with autosomal dominant inheritance have been reported.
The pathophysiology involves mechanical restriction of the superior oblique tendon as it passes through the trochlea. Normally, the tendon glides smoothly, allowing coordinated eye movement. In Brown syndrome, the tendon may be tight, inelastic, inflamed, or mechanically restricted, preventing normal elevation of the eye in adduction. This distinguishes it from neurogenic causes of motility limitation, as the issue is mechanical rather than due to muscle weakness.
Etiologically, congenital cases are typically due to a short or inelastic superior oblique tendon. Acquired cases may result from trauma to the tendon or trochlea, or from inflammatory conditions such as Juvenile Idiopathic Arthritis or Rheumatoid Arthritis. Inflammatory cases may present with pain, swelling, and tenderness in the superonasal orbit.
Patients may present with abnormal eye movements, particularly difficulty looking upward when the eye is turned inward. Diplopia may occur in upgaze, especially in acquired cases. Some patients report a clicking sensation with attempted elevation. To compensate, individuals may adopt a chin-up posture or turn their face away from the affected eye to maintain binocular vision. On examination, there is limited elevation in adduction with normal elevation in abduction. A hypotropia may be present in primary gaze or in gaze away from the affected side, and in acquired cases, tenderness or swelling over the trochlear region may be noted.
Diagnosis is primarily clinical, supported by findings such as a positive forced duction test indicating mechanical restriction. Imaging such as MRI may show inflammation or enhancement in the trochlear region in acquired cases but is not required for diagnosis. Laboratory evaluation may be indicated when an inflammatory cause is suspected, including tests for autoimmune disease.
Management depends on the cause and severity. Many congenital cases do not require treatment, as patients adapt well without significant symptoms. In acquired inflammatory cases, treatment of the underlying condition often leads to resolution. Nonsteroidal anti-inflammatory drugs may be used initially, with corticosteroids or local steroid injections considered for persistent inflammation.
Surgical intervention is reserved for patients with significant head posture, hypotropia in primary gaze, or troublesome diplopia. Procedures aim to relieve the restriction of the superior oblique tendon, such as tenotomy or tendon lengthening techniques, while minimizing the risk of postoperative complications like inferior oblique overaction.
The prognosis is generally good. Congenital cases often remain stable and may not require intervention, while acquired cases—especially those related to inflammation—frequently resolve with appropriate medical management. Long-term follow-up is important to monitor for amblyopia, persistent diplopia, or changes in ocular alignment.
- Published on
Emergency and Acute Medicine – Torticollis
Torticollis, meaning “twisted neck,” is a clinical symptom rather than a disease entity. It refers to a fixed or dynamic abnormal posture of the head and neck, often involving rotation or tilting. It is also known as cervical dystonia or wry neck and may arise from a wide range of local or central causes.
The etiology of torticollis is broad and can be categorized into local and central causes. The most common form is acute wry neck, which typically develops अचानक (often overnight) without clear provocation and resolves spontaneously within 1–2 weeks. Local structural causes include cervical spine pathology such as fractures, dislocations, subluxations, spondylosis, tumors, ligamentous laxity (especially in the atlantoaxial region), and scar tissue from prior injury. Inflammatory or infectious causes include myositis, lymphadenitis, tuberculosis, and infections of surrounding tissues such as retropharyngeal abscess, meningitis, tonsillitis, mastoiditis, or sinusitis. Neurologic and neuromuscular causes include myasthenia gravis and neuritis. Compensatory torticollis may occur with ocular muscle palsy or head tremor.
Central causes include idiopathic spasmodic torticollis, which is more common in women aged 31–60 years, as well as dystonic disorders such as torsion dystonia, tardive dystonia from neuroleptic medications, Wilson disease, and toxic causes such as Strychnine poisoning. Drug-induced dystonia, particularly from antipsychotics, is a common acute cause and typically occurs within 12–23 hours of medication exposure.
In pediatric patients, causes include congenital abnormalities such as muscular torticollis due to sternocleidomastoid hypertrophy, vertebral anomalies, or syndromic conditions. Other causes include infections (e.g., otitis media, retropharyngeal abscess), trauma, gastroesophageal reflux, and central nervous system pathology such as posterior fossa tumors.
Clinically, patients present with intermittent or sustained painful spasms of the neck muscles, particularly the sternocleidomastoid and trapezius. The head is typically rotated and tilted to one side, with movements ranging from smooth deviation to jerking motions. Pure flexion (anterocollis) or extension (retrocollis) is uncommon. Symptoms are often exacerbated by activity, stress, or upright posture and typically resolve during sleep.
History should focus on recent trauma, medication exposure (especially antipsychotics), and systemic symptoms such as fever. On examination, the abnormal head posture is evident, and neurologic evaluation is essential. The presence of fever suggests an infectious cause, while focal neurologic deficits raise concern for central nervous system or spinal cord pathology. In congenital cases, a firm, nontender mass in the sternocleidomastoid muscle may be present.
Evaluation is directed at excluding serious causes. Cervical spine imaging is indicated when trauma is suspected. CT or MRI may be required if there is concern for abscess, tumor, or neurologic pathology. Ultrasound is the preferred modality for congenital muscular torticollis. No specific laboratory tests are routinely helpful.
Management depends on the underlying cause. Prehospital care includes ensuring airway patency, supporting the head, and maintaining cervical spine precautions if trauma is suspected. In the emergency setting, immobilization is essential when fracture is a concern.
For drug-induced torticollis, treatment with diphenhydramine or benztropine is highly effective. For non-drug-related cases, conservative management includes rest, soft cervical collar, physical therapy, massage, local heat, and analgesics. Benzodiazepines may be used for muscle relaxation. Botulinum toxin is the first-line treatment for chronic or non–drug-induced torticollis, although it is typically administered in an outpatient setting.
Patients require admission if there is suspicion of cervical spine fracture, infection, toxic appearance, inability to maintain hydration, or diagnostic uncertainty. Most uncomplicated cases can be managed as outpatients with referral to specialists such as neurologists, orthopedists, or neurosurgeons.
Key clinical pearls include always excluding serious causes such as infection (e.g., retropharyngeal abscess or meningitis), trauma, and central nervous system pathology before attributing symptoms to benign torticollis. Drug-induced dystonia is common and rapidly reversible with appropriate treatment, and failure to recognize life-threatening causes can lead to significant morbidity.
- Published on
Emergency and Acute Medicine – Toothache
Toothache is a common presentation caused by irritation of the nerve endings within the dental pulp, which contains the tooth’s neurovascular supply. Although most causes are odontogenic, pain may also originate from non-dental sources and be referred to the oral cavity via the distribution of the trigeminal nerve.
The most common etiologies are dental in origin. Dental caries, resulting from bacterial demineralization of tooth structures, can progress to pulpitis, which may be reversible or irreversible depending on severity. Reversible pulpitis causes mild inflammation and transient pain, whereas irreversible pulpitis leads to severe, persistent, and poorly localized pain. If untreated, this may progress to a periapical abscess involving necrotic pulp and surrounding tissues. Other dental causes include periodontal disease (gingivitis and periodontitis), periodontal abscess, pericoronitis (often associated with partially erupted wisdom teeth), cracked-tooth syndrome, postextraction complications such as dry socket, and mucosal conditions such as aphthous ulcers or herpetic gingivostomatitis.
Patients typically present with localized or referred tooth pain that may radiate to the jaw, ear, face, eye, or neck. The pain is often exacerbated by chewing, temperature changes, or lying flat. Associated symptoms may include foul taste, bad breath, fever, or facial swelling. A detailed history should include onset, duration, prior treatments, and associated systemic symptoms.
Physical examination should be thorough and systematic. Findings may include visible dental decay, gingival inflammation, swelling, or trismus (reduced mouth opening). The clinician should inspect and palpate oral structures, assess for lymphadenopathy, and evaluate for signs of deep-space infection such as floor-of-mouth swelling or voice changes. Percussion of teeth may reveal tenderness, and examination for fractures, mobility, or missing teeth is essential. Facial and neck examination should assess for cellulitis, warmth, and stiffness.
Diagnosis is primarily clinical. Laboratory tests are generally not required unless there are signs of systemic toxicity or deep-space infection, in which case inflammatory markers and cultures may be considered. Imaging such as panoramic or periapical radiographs may help identify abscesses or fractures, while CT or MRI is reserved for suspected deep infections. Dental nerve blocks can provide both diagnostic and therapeutic benefit in selected cases.
Management focuses on pain control and treatment of the underlying cause. NSAIDs are first-line therapy for uncomplicated dental pain, with opioids reserved for severe cases. Local or regional dental nerve blocks using long-acting anesthetics such as bupivacaine can provide effective relief. If infection is present, antibiotics are indicated, with penicillin as first-line therapy and clindamycin for penicillin-allergic patients or suspected anaerobic infections.
Localized abscesses should be incised, drained, and irrigated, followed by saline rinses and prompt dental follow-up. Most patients can be discharged with appropriate analgesia, antibiotics if indicated, and referral to a dentist or oral surgeon. However, admission is required for serious complications such as deep-space infections (e.g., Ludwig angina), facial cellulitis near the eye, significant trismus, inability to maintain hydration, or systemic toxicity.
Key clinical pearls include recognizing that dental pain can be referred from non-dental sources such as sinusitis, temporomandibular joint disorders, or even cardiac ischemia. Failure to identify deep-space infections can lead to life-threatening complications, so careful assessment is essential. Prompt dental follow-up is critical, as emergency department treatment is only temporizing and does not address the definitive underlying pathology.
- Published on
Emergency and Acute Medicine – Toluene Poisoning
Toluene poisoning results from exposure to a volatile hydrocarbon that is a clear, colorless liquid with a characteristic sweet odor. It is widely used as an organic solvent in products such as paints, thinners, glues, inks, correction fluid, petroleum products, and aerosolized household items. Exposure may occur occupationally or through intentional abuse, particularly among adolescents due to its low cost and easy accessibility. Methods of abuse include sniffing directly from a container, huffing vapors from a soaked cloth, and bagging vapors in a confined space for inhalation.
Toluene is rapidly absorbed through inhalation and readily crosses the blood–brain barrier, achieving high concentrations in the brain. It exerts multiple toxic effects, including central nervous system depression, myocardial sensitization to catecholamines, and disruption of cardiac ion channels, predisposing to dangerous dysrhythmias. It is metabolized in the liver and excreted through the lungs and urine. Toxicity is dose-dependent, ranging from mild impairment at lower concentrations to anesthesia, seizures, and death at very high levels.
Clinically, acute toxicity primarily affects the neurologic, cardiac, pulmonary, and metabolic systems. Patients may present with euphoria, dizziness, ataxia, confusion, or seizures. Cardiac effects are particularly dangerous and include potentially fatal dysrhythmias, especially in the setting of catecholamine surges (“sudden sniffing death”). Pulmonary complications include chemical pneumonitis and pulmonary edema. Metabolic abnormalities are characteristic and include hypokalemia, hypocalcemia, and a hyperchloremic metabolic acidosis due to accumulation of hippuric acid. Gastrointestinal symptoms such as nausea, vomiting, and abdominal pain may occur, and renal effects include distal renal tubular acidosis, hematuria, and proteinuria.
Chronic exposure leads to progressive and often irreversible damage. Neurologic complications include peripheral neuropathy, leukoencephalopathy, cerebellar dysfunction, and cognitive impairment. Cardiac complications may include dilated cardiomyopathy and persistent dysrhythmias. Renal injury may progress to chronic failure, and musculoskeletal complications such as rhabdomyolysis can occur. Chronic abuse is also associated with psychiatric issues and addiction. In pregnancy, chronic exposure has been linked to fetal solvent syndrome, resembling fetal alcohol syndrome with growth restriction and developmental delay.
Diagnosis is primarily clinical, supported by history of exposure and physical findings such as solvent odor, perioral dermatitis, or evidence of inhalant use on clothing or skin. Laboratory evaluation typically reveals electrolyte abnormalities, particularly hypokalemia and metabolic acidosis. Renal function tests, creatine kinase (if rhabdomyolysis is suspected), and liver function tests should be obtained. Urinary hippuric acid may confirm exposure but does not correlate with severity. Imaging studies include ECG to detect dysrhythmias and chest radiography if respiratory symptoms are present.
Management focuses on supportive care and stabilization. Initial priorities include airway, breathing, and circulation, with supplemental oxygen, cardiac monitoring, and intravenous fluids. Sudden cardiac death is a major risk due to myocardial sensitization, so careful monitoring is essential. Dysrhythmias should be treated according to standard protocols, with consideration of β-blockers for tachydysrhythmias. Respiratory status should be monitored closely, and chemical pneumonitis is managed supportively, as steroids are not recommended.
Metabolic abnormalities should be corrected, including cautious repletion of potassium, calcium, and phosphate. Acidosis generally improves with fluid resuscitation. In cases of rhabdomyolysis, aggressive hydration is required to maintain urine output. Gastrointestinal decontamination is generally not useful and may increase the risk of aspiration; activated charcoal is ineffective for hydrocarbons.
Disposition depends on clinical severity. Patients with altered mental status, dysrhythmias, significant metabolic disturbances, renal failure, or rhabdomyolysis require admission. Those who return to baseline mental status and remain stable after 4–6 hours of observation without evidence of complications may be discharged.
Key clinical pearls include the risk of sudden death due to catecholamine-induced dysrhythmias and the importance of monitoring and correcting electrolyte abnormalities. Cardiac complications carry a poor prognosis, and cessation of exposure is the most important long-term intervention. Referral for psychiatric evaluation and substance abuse counseling is essential in cases of intentional or repeated use.
- Published on
Ophthalmology – Branch Retinal Vein Occlusion (BRVO)
Branch retinal vein occlusion (BRVO) is a retinal vascular disorder characterized by obstruction of blood flow in a branch retinal vein, typically at an arteriovenous crossing. It commonly presents with painless, variable vision loss, which may be blurred or distorted. Clinically, BRVO is classified into ischemic and nonischemic types, which differ in severity, prognosis, and risk of complications. It primarily affects individuals over 50 years of age, while pediatric cases are rare and often associated with identifiable systemic causes such as hypercoagulable states.
Epidemiologically, BRVO is the second most common retinal vascular disorder after diabetic retinopathy and is more common than central retinal vein occlusion. Its incidence increases with age, with a 15-year cumulative incidence of approximately 1.8% reported in population studies. The overall prevalence ranges from 0.6% to 1.6%, affecting both men and women equally.
The strongest risk factor for BRVO is systemic hypertension, present in the majority of patients. Other important risk factors include diabetes mellitus, hyperlipidemia, obesity, cardiovascular disease, and hyperviscosity syndromes. In younger patients, evaluation for thrombophilia or systemic disease is essential, as BRVO is less commonly idiopathic in this group.
Pathophysiologically, BRVO is believed to result from mechanical compression of a retinal vein by an adjacent artery at arteriovenous crossing points, where both share a common sheath. This leads to turbulent flow, endothelial injury, and thrombus formation—components of Virchow’s triad. The resulting venous obstruction causes increased hydrostatic pressure, retinal hemorrhage, and capillary leakage. Hypoxia stimulates increased production of vascular endothelial growth factor (VEGF), contributing to macular edema and neovascularization, which are major causes of vision loss.
Patients typically present with sudden or gradual vision loss, depending on the extent and location of involvement. Fundus examination reveals sectoral flame-shaped hemorrhages in the distribution of the affected vein, along with dilated and tortuous vessels. Additional findings may include cotton wool spots, microaneurysms, retinal edema, and, in chronic stages, collateral vessel formation and retinal pigment epithelial changes. The superotemporal quadrant is most commonly affected.
Diagnosis is primarily clinical, supported by imaging. Fluorescein angiography demonstrates delayed venous filling, leakage, and areas of capillary nonperfusion, particularly in ischemic BRVO (defined as greater than five disc areas of nonperfusion). Optical coherence tomography (OCT) is essential for detecting and monitoring macular edema. Laboratory investigations are generally unnecessary in older patients with known vascular risk factors but are important in younger patients to evaluate for systemic or hypercoagulable conditions.
Management focuses on treating complications such as macular edema and neovascularization. First-line therapy includes intravitreal anti-VEGF agents such as bevacizumab, ranibizumab, or dexamethasone implants, which reduce edema and improve visual outcomes. Historically, macular grid laser photocoagulation was used for persistent edema, and it remains an option in selected cases. Panretinal photocoagulation is indicated for neovascular complications but is not used prophylactically. In refractory cases, surgical options such as vitrectomy may be considered.
Patients require close follow-up, typically monthly for the first three months and then at regular intervals, with monitoring using OCT, fluorescein angiography, and visual field testing. Coordination with a primary care physician is important to manage systemic risk factors and prevent recurrence or progression.
The prognosis for BRVO is generally favorable, with about half of patients achieving visual acuity of 20/40 or better. However, outcomes vary depending on the extent of ischemia, presence of macular edema, and development of complications. Conversion from nonischemic to ischemic BRVO can occur, making prognosis unpredictable. Major complications include macular edema, macular ischemia, retinal neovascularization, and vitreous hemorrhage, all of which can significantly impact vision.
- Published on
Ophthalmology – Bartonella Neuroretinitis
Bartonella neuroretinitis is a form of neuroretinitis characterized by optic disc swelling accompanied by a distinctive pattern of hard exudates radiating from the macula in a “macular star” configuration. The most common infectious cause is Bartonella henselae, a gram-negative bacillus associated with cat-scratch disease. While neuroretinitis can result from various infectious and inflammatory conditions, Bartonella infection remains the leading identifiable etiology.
This condition can affect individuals of all ages but is most commonly seen in patients in their third to fourth decades of life. There is no clear gender predilection. A key risk factor is exposure to cats, particularly kittens, as transmission typically occurs through scratches or bites. Other infectious causes of neuroretinitis include syphilis, viral infections, toxoplasmosis, toxocariasis, histoplasmosis, and Lyme disease. Noninfectious causes such as sarcoidosis may also present similarly and should be considered in the differential diagnosis.
Patients typically present with visual complaints such as blurred vision and eye discomfort, often worsened by eye movement. Systemic symptoms may accompany the ocular findings, especially in cases related to cat-scratch disease, and can include fever, malaise, headache, and muscle aches. A detailed history is important, including animal exposure, travel, dietary habits, and sexual history, to help identify potential infectious etiologies.
On examination, visual acuity can range widely from normal to severely reduced, even to light perception in some cases. Common findings include decreased color vision, a relative afferent pupillary defect, and optic disc edema. The hallmark feature is the presence of macular hard exudates arranged in a star pattern around the fovea. Additional findings may include splinter hemorrhages, retinal vascular occlusions, small yellow-white retinal or choroidal infiltrates, and vitreous inflammation. In systemic Bartonella infection, patients may also exhibit lymphadenopathy, arthritis, or neurologic involvement such as meningitis or encephalitis.
Diagnosis is primarily clinical but supported by laboratory and imaging studies. Serologic testing for Bartonella henselae is commonly used, with ELISA being widely available. Testing for other infectious causes should be performed as indicated. Fluorescein angiography typically demonstrates optic disc leakage and staining of peripapillary vessels. Visual field testing often reveals a cecocentral scotoma, which is the most common defect associated with this condition.
The differential diagnosis includes optic neuritis and other forms of optic neuropathy, which may present with similar visual symptoms but lack the characteristic macular star. Identifying the underlying cause is crucial for appropriate management.
Treatment of Bartonella neuroretinitis generally involves antibiotic therapy. First-line treatment for cat-scratch disease includes oral ciprofloxacin, although other antibiotics such as azithromycin, doxycycline, erythromycin, or rifampin may also be used depending on clinical circumstances. Patients should be co-managed with a primary care physician or infectious disease specialist, in addition to close ophthalmologic follow-up.
The prognosis is typically favorable, as Bartonella neuroretinitis is often self-limited. Optic disc swelling usually resolves within 6 to 8 weeks, while macular exudates may take 6 to 12 months to fully resolve. Some patients may experience persistent visual symptoms such as mild blurring or metamorphopsia, and residual optic disc pallor can occur. Recurrence is uncommon. Potential complications include permanent visual loss and systemic complications related to the underlying infectious or inflammatory condition.
- Published on
Ophthalmology – Behçet’s Disease
Behçet’s disease is a multisystem inflammatory disorder characterized by a systemic vasculitis affecting small blood vessels. It classically presents with a triad of recurrent oral aphthous ulcers, genital ulcers, and uveitis, although skin lesions and systemic involvement are also common. The ocular manifestations are particularly important, as they can range from mild anterior uveitis to severe, sight-threatening retinal vasculitis. The disease tends to follow a relapsing-remitting course and can involve multiple organ systems.
Epidemiologically, Behçet’s disease is most prevalent along the historic “Silk Road,” particularly in countries such as Turkey, Japan, the Middle East, and parts of Asia. It most commonly affects young adults between the ages of 25 and 35, although it can occur at any age. While earlier reports suggested a male predominance, more recent data indicate a more equal distribution between sexes. The disease is rare in North America. Genetic predisposition plays a role, with a strong association with the HLA-B51 allele, while environmental or infectious triggers such as streptococcal organisms and viruses have been proposed but not definitively proven.
The pathophysiology involves an abnormal immune response leading to a nonspecific obliterative vasculitis. Dysfunction of lymphocytes and immune regulation results in inflammation and damage to blood vessels throughout the body. This explains the wide range of systemic and ocular manifestations seen in affected patients.
Diagnosis of Behçet’s disease is clinical, as there is no single confirmatory laboratory test. The most widely used criteria require recurrent oral ulcers (at least three times in one year) along with at least two of the following: recurrent genital ulcers, ocular inflammation, skin lesions, or a positive pathergy test. Oral ulcers are the most common feature, occurring in nearly all patients, and appear as painful, well-defined lesions with a red border. Genital ulcers may be painful or painless and often recur. Skin findings include erythema nodosum, acneiform eruptions, and superficial thrombophlebitis.
Ocular involvement occurs in a majority of patients and is a major cause of morbidity. Patients typically present with eye pain, redness, photophobia, and blurred vision. Anterior segment findings include nongranulomatous anterior uveitis, sometimes with a shifting hypopyon, although hypopyon is less common today due to earlier treatment. Posterior segment involvement is more severe and includes retinal vasculitis affecting both arteries and veins, vitreitis, vascular occlusion, and retinal ischemia. These changes can lead to complications such as neovascularization and vision loss. Neuro-ophthalmic findings, including cranial nerve palsies and optic disc edema, may occur in cases with central nervous system involvement.
Evaluation includes a thorough clinical examination and may be supported by laboratory testing. Although routine labs are often nonspecific, tests such as HLA-B51 typing and the pathergy test can support the diagnosis. Imaging studies, particularly fluorescein angiography, are essential in assessing retinal vascular involvement and monitoring disease progression. In cases with suspected neurologic involvement, MRI and cerebrospinal fluid analysis may be required.
Management depends on disease severity and organ involvement. Mild disease may be managed conservatively, but moderate to severe cases—especially those with ocular, neurologic, or vascular involvement—require aggressive immunosuppressive therapy. Systemic corticosteroids are often used initially for rapid control of inflammation, but long-term use necessitates steroid-sparing agents. These include immunosuppressive drugs such as azathioprine, mycophenolate mofetil, cyclosporine, and tacrolimus, as well as cytotoxic agents like cyclophosphamide. Biologic therapies, particularly tumor necrosis factor (TNF) inhibitors such as infliximab and adalimumab, have become increasingly important in controlling severe disease. A multidisciplinary approach involving ophthalmologists, rheumatologists, and other specialists is essential.
Patients with ocular involvement require urgent referral to a uveitis or retinal specialist due to the high risk of vision loss if treatment is delayed. Surgical interventions, such as cataract extraction, may be performed once inflammation is well controlled, while laser photocoagulation may be used to treat retinal neovascularization.
The prognosis of Behçet’s disease has improved significantly with modern immunosuppressive and biologic therapies, although visual outcomes can still be guarded. Without adequate treatment, a high proportion of patients may develop severe visual impairment or blindness. Systemic prognosis is generally favorable in the absence of major complications such as central nervous system involvement or large-vessel disease. Over time, many patients experience longer periods of remission, and disease activity may stabilize after approximately a decade.
Complications primarily relate to chronic inflammation and vascular damage. Ocular complications include cataract, glaucoma, retinal ischemia, neovascularization, vitreous hemorrhage, retinal detachment, and optic nerve damage, all of which can contribute to permanent vision loss.
- Published on
Ophthalmology – Best’s Vitelliform Macular Dystrophy
Best’s vitelliform macular dystrophy, also known as Best’s disease, is a rare inherited retinal disorder characterized by bilateral involvement of the macula and a distinctive yellow “egg-yolk” lesion. It follows an autosomal dominant inheritance pattern and is caused by mutations in the BEST1 gene on chromosome 11q13, which encodes the bestrophin-1 protein. Although the age of onset is variable, the disease most commonly presents during childhood or adolescence.
The underlying pathophysiology involves dysfunction of bestrophin-1, a calcium-activated chloride channel located in the retinal pigment epithelium (RPE). This dysfunction leads to impaired ion transport and accumulation of lipofuscin between the neurosensory retina and the RPE. Over time, this buildup produces the characteristic vitelliform lesion and contributes to progressive retinal changes.
Patients often present with mild visual symptoms such as blurred vision or metamorphopsia, although some may remain asymptomatic in early stages. A positive family history of retinal dystrophy is an important clue. On examination, the anterior segment is typically normal, while fundus evaluation reveals the classic yellow lesion in the central macula. The disease progresses through several stages, beginning with subtle RPE changes and advancing to the vitelliform “egg-yolk” stage. Later stages may show fragmentation of the lesion (“scrambled egg”), layering of material (pseudohypopyon), and eventual atrophy or scarring. In some cases, complications such as choroidal neovascularization can develop.
Diagnostic testing plays a key role in confirming the diagnosis. A hallmark finding is a normal full-field electroretinogram (ERG) with an abnormal electrooculogram (EOG), reflecting RPE dysfunction. The Arden ratio is typically reduced. Imaging studies such as optical coherence tomography (OCT) demonstrate subretinal deposits and structural changes, while fundus autofluorescence shows increased autofluorescence corresponding to lipofuscin accumulation. Fluorescein angiography may reveal blockage from lesions or leakage if neovascularization is present. Genetic testing can confirm mutations in the BEST1 gene.
There is no specific medical treatment for Best’s disease itself. Management primarily involves observation and regular follow-up with a retina specialist. Patients are monitored for disease progression and complications, particularly choroidal neovascularization. If such complications arise, treatment options include intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy or photodynamic therapy.
The prognosis is generally favorable, with many patients maintaining visual acuity of 20/40 or better for a significant portion of their lives. However, visual outcomes can vary depending on disease progression and the development of complications. Choroidal neovascularization remains the most important cause of vision loss in affected individuals. Genetic counseling is recommended for patients and their families due to the hereditary nature of the condition.
- Published on
Ophthalmology – Benign Conjunctival Lesions
Benign conjunctival lesions represent a diverse group of nonmalignant growths affecting the conjunctiva, including papilloma, Kaposi’s sarcoma, limbal dermoid, sarcoidosis-related nodules, and pyogenic granuloma. These lesions have a low potential for malignant transformation but vary widely in their causes, clinical appearance, and management. While many are asymptomatic, they may produce symptoms due to mass effect or cosmetic concerns.
The epidemiology varies depending on the specific lesion. Kaposi’s sarcoma may involve the ocular adnexa in a subset of patients with systemic disease, particularly in immunocompromised individuals. Sarcoidosis can involve the conjunctiva in a smaller proportion of systemic cases. Limbal dermoids are typically congenital and present early in life, whereas other lesions such as papillomas or pyogenic granulomas may occur at any age depending on underlying risk factors.
Risk factors differ among lesion types. Conjunctival papillomas are associated with human papillomavirus (HPV), often transmitted during childbirth or through direct contact, and may also be influenced by ultraviolet exposure. Kaposi’s sarcoma is strongly linked to immunosuppression, including HIV/AIDS, chemotherapy, organ transplantation, and advanced age. Limbal dermoids are congenital lesions, sometimes associated with syndromes such as Goldenhar syndrome. Sarcoidosis is more common in African American patients and is associated with systemic granulomatous disease. Pyogenic granulomas often arise following ocular surgery, trauma, or chronic inflammation as part of an exaggerated wound-healing response.
The pathophysiology reflects the underlying cause of each lesion. Papillomas result from viral-induced epithelial proliferation, while Kaposi’s sarcoma arises from vascular proliferation driven by human herpesvirus-8. Limbal dermoids are choristomas containing normal tissue in an abnormal location, often including hair follicles and sebaceous glands. Sarcoidosis leads to noncaseating granulomatous inflammation, and pyogenic granulomas represent reactive fibrovascular proliferation following injury or inflammation.
Patients may present with a variety of symptoms, although many lesions are discovered incidentally. When symptomatic, patients may report foreign body sensation, irritation, tearing, itching, photophobia, or blurred vision. Larger lesions can cause mechanical effects such as ptosis, trichiasis, or poor eyelid apposition. A thorough history is important, including immune status, systemic symptoms suggestive of sarcoidosis, prior ocular surgery or trauma, and congenital onset in the case of limbal dermoids.
On examination, the appearance of the lesion often suggests the diagnosis. Papillomas typically appear as pink-red, fleshy, pedunculated or sessile lesions, sometimes with a verrucous surface. Kaposi’s sarcoma presents as a reddish-purple, flat or nodular lesion. Sarcoid lesions are usually yellow or salmon-colored nodules, often located in the inferior conjunctival fornix. Limbal dermoids appear as yellowish-white, well-circumscribed masses near the limbus and may contain fine hairs. Pyogenic granulomas are highly vascular, red, elevated lesions often attached by a stalk. Secondary findings may include conjunctival swelling, corneal irritation, or surface damage.
Diagnosis is primarily clinical but may be supported by laboratory and imaging studies when systemic disease is suspected. For example, HIV testing is indicated in suspected Kaposi’s sarcoma, while serum angiotensin-converting enzyme levels and chest imaging may aid in diagnosing sarcoidosis. Biopsy, either incisional or excisional, is recommended when there is concern for malignancy or when the diagnosis is uncertain.
Management depends on the specific lesion and symptom severity. Many lesions, such as papillomas and pyogenic granulomas, may resolve spontaneously and can be observed initially. Topical treatments, such as steroids for sarcoidosis or lubrication for limbal dermoids, may provide symptomatic relief. Kaposi’s sarcoma is managed primarily with systemic therapy such as highly active antiretroviral therapy in HIV-positive patients. For persistent, symptomatic, or suspicious lesions, surgical excision is often indicated, sometimes combined with adjunctive therapies such as cryotherapy or topical medications.
The prognosis for benign conjunctival lesions is generally excellent. Most lesions remain stable or resolve with appropriate management, although recurrence can occur, particularly after surgical removal. Complications are uncommon but may include scarring, infection, or, in the case of limbal dermoids, residual corneal opacity or refractive error. In some cases, systemic complications may arise depending on the underlying associated condition, emphasizing the importance of a comprehensive evaluation.
- Published on
Ophthalmology – Blepharospasm and Hemifacial Spasm
Blepharospasm and hemifacial spasm are movement disorders involving involuntary contractions of facial muscles. Blepharospasm refers to bilateral, involuntary eyelid closure due to spasms of the eyelid muscles, while hemifacial spasm involves unilateral contractions of muscles supplied by the facial nerve. These conditions primarily affect the nervous and musculoskeletal systems and are most commonly seen in middle-aged adults, with a higher prevalence in women.
Blepharospasm may be classified as essential (idiopathic), associated with dystonia (such as Meige syndrome, which involves the face, jaw, and neck), or secondary to ocular irritation such as dry eye or inflammation. Hemifacial spasm, on the other hand, is typically caused by vascular compression of the facial nerve, although rarely tumors in the posterior fossa may be responsible.
The pathophysiology of blepharospasm involves abnormal simultaneous contraction of opposing muscle groups: the eyelid protractors (such as the orbicularis oculi) and retractors (such as the levator palpebrae). There may also be increased sensitivity of the trigeminal system, particularly in patients with photophobia. In hemifacial spasm, abnormal nerve transmission (ephaptic transmission) occurs due to irritation or compression of the facial nerve, leading to synchronous contractions of facial muscles.
Clinically, patients with blepharospasm initially experience increased blinking, which progresses to involuntary, forceful eyelid closure that may become disabling. Symptoms may begin unilaterally but usually become bilateral. Ocular irritation is often present. In hemifacial spasm, patients develop intermittent twitching around one eye that gradually spreads to involve other muscles on the same side of the face. These spasms are typically synchronous and persist during sleep in some cases.
On examination, blepharospasm is characterized by nonvolitional contraction of multiple eyelid muscles, not just the orbicularis. It is important to exclude underlying ocular causes such as dry eye or eyelid abnormalities. Hemifacial spasm presents with coordinated, unilateral contractions of facial muscles. Neuroimaging, particularly MRI or MRA of the brain with attention to the posterior fossa, is recommended to evaluate for vascular compression or other structural causes.
Treatment focuses on symptom control. Botulinum toxin injections are the first-line therapy for both conditions and are highly effective, with about 90% of patients experiencing improvement. These injections are typically administered every 3–4 months. Oral medications such as carbamazepine, baclofen, or clonazepam may be used but are often less effective and can cause sedation. In cases of hemifacial spasm due to vascular compression, microvascular decompression surgery may be considered. Surgical options for blepharospasm, such as orbicularis myectomy, are reserved for refractory cases.
Regular follow-up is important, especially after botulinum injections, to assess response and determine the timing of repeat treatment. Patients should be educated about the chronic nature of these conditions and reassured that effective treatment options are available. Reducing triggers such as stress or excessive caffeine intake may help in some cases.
The prognosis is generally favorable, particularly with botulinum toxin therapy. However, untreated or severe cases can significantly impact quality of life due to functional visual impairment. Surgical interventions, while effective in selected cases, carry risks such as facial weakness or hearing loss, particularly in procedures involving the facial nerve.
